within Pharmacolibrary.Drugs.ATC.D;

model D07AB03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.01,
    Cl             = 0 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 0.1 / 1000000,
    adminCount     = 1,
    Vd             = 0,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Flumetasone is a synthetic corticosteroid used primarily for its anti-inflammatory and anti-allergic properties. It has been formulated for topical applications (e.g., creams and ointments) for dermatological conditions and occasionally used in veterinary medicine. While flumetasone is approved for topical use in many countries, its systemic use in humans is limited.</p><h4>Pharmacokinetics</h4><p>No pharmacokinetic (PK) studies in humans have been published describing systemic PK parameters such as clearance, volume of distribution, or absorption rate. Most available data pertain to topical administration with negligible systemic absorption in healthy adults.</p><h4>References</h4><ol><li><p>Holzmann, H, &amp; Morsches, B (1979). [Studies on percutaneous absorption of flumetasone pivalate and salicylic acid from a corticoid combination for topical use (author&#x27;s transl)]. <i>Arzneimittel-Forschung</i> 29(4) 688–693. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/582770/&quot;>https://pubmed.ncbi.nlm.nih.gov/582770</a></p></li><li><p>Barry, BW, &amp; Woodford, R (1974). Comparative bio-availability of proprietary topical corticosteroid preparations; vasoconstrictor assays on thirty creams and gels. <i>The British journal of dermatology</i> 91(3) 323–338. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2133.1974.tb12903.x&quot;>10.1111/j.1365-2133.1974.tb12903.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/4611447/&quot;>https://pubmed.ncbi.nlm.nih.gov/4611447</a></p></li><li><p>Schlatter, C, &amp; Ueltschi, G (1974). [Skin penetration of topically applied drugs]. <i>Experientia</i> 30(8) 933–935. DOI:<a href=&quot;https://doi.org/10.1007/BF01938371&quot;>10.1007/BF01938371</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/4410891/&quot;>https://pubmed.ncbi.nlm.nih.gov/4410891</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D07AB03;
